TAp73 and ΔNp73 Have Opposing Roles in 5-aza-2'-Deoxycytidine-Induced Apoptosis in Breast Cancer Cells

다국어 초록 (Multilingual Abstract)

The p73 gene contains an extrinsic P1 promoter and an intrinsic P2 promoter, controlling the transcription of the pro-apoptotic TAp73 isoform and the anti-apoptotic ΔΝp73 isoform, respectively. The DNA methylation status of both promoters act equally in the epigenetic transcriptional regulation of their relevant isoforms. The aim of this study was to analyze the different effects of these p73 isoforms in 5-aza-2'-deoxycytidine (5-aza-dC)-induced apoptosis in breast cancer cells. We investigated the effects of the DNA demethylation agent, 5-aza-dC, on the T-47D breast cancer cell line, and evaluated the methylation status of the p73 promoters and expression of TAp73 and ΔNp73. Furthermore, we assessed the expression of p53 and p73 isoforms in 5-aza-dC-treated T-47D cells and p53 knockout cells. 5-aza-dC induced significant anti-tumor effects in T-47D cells, including inhibition of cell viability, G1 phase arrest and apoptosis. This was associated with p73 promoter demethylation and a concomitant increase in TAp73 mRNA and protein expression. In contrast, the methylation status of promoter P2 was not associated with ΔNp73 mRNA or protein levels. Furthermore, demethylation of P2 failed to inhibit the expression of ΔNp73 with 5-aza-dC in the p53 knockdown cell model. Our study suggests that demethylation of the P1 and P2 promoters has opposite effects on the expression of p73 isoforms, namely up-regulation of TAp73 and down-regulation of ΔΝp73. We also demonstrate that p53 likely contributes to 5-aza-dC-induced ΔNp73 transcriptional inactivation in breast cancer cells.

참고문헌 (Reference)

1 Ozaki, T., "p73, a sophisticated p53 family member in the cancer world" 96 : 729-737, 2005

2 Ramadan, S., "p73 induces apoptosis by different mechanisms" 331 : 713-717, 2005

3 Ushiku, T., "p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma" 120 : 60-66, 2007

4 Willis, A. C., "p73 can suppress the proliferation of cells that express mutant p53" 22 : 5481-5495, 2003

5 Melino, G., "p73 : Friend or foe in tumorigenesis" 2 : 605-615, 2002

6 Moll, U. M., "p63 and p73 : roles in development and tumor formation" 2 : 371-386, 2004

7 Murray-Zmijewski, F., "p53/p63/p73 isoforms : an orchestra of isoforms to harmonise cell differentiation and response to stress" 13 : 962-972, 2006

8 Kartasheva, N. N., "p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop" 21 : 4715-4727, 2002

9 Tophkhane, C., "p53 inactivation upregulates p73 expression through E2F-1 mediated transcription" 7 : e43564-, 2012

10 Ikawa, S., "p53 family genes : structural comparison, expression and mutation" 6 : 1154-1161, 1999

11 Stiewe, T., "Transactivation-deficient DeltaTA-p73 acts as an oncogene" 62 : 3598-3602, 2002

12 Jones, P. A., "The fundamental role of epigenetic events in cancer" 3 : 415-428, 2002

13 Tomasini, R., "TAp73 knockout shows genomic instability with infertility and tumor suppressor functions" 22 : 2677-2691, 2008

14 Gonzalez-Cano, L., "Regulatory feedback loop between TP73 and TRIM32" 4 : e704-, 2013

15 Gonzalez-Gomez, P., "Promoter methylation status of multiple genes in brain metastases of solid tumors" 13 : 93-98, 2004

16 Jha, A. K., "Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population" 39 : 9145-9157, 2012

17 Ishimoto, O., "Possible oncogenic potential of DeltaNp73 : a newly identified isoform of human p73" 62 : 636-641, 2002

18 Nakagawa, T., "Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells" 197 : 105-109, 2003

19 Sato, H., "Multistep aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma" 176 : 402-415, 2010

20 Kong, W. J., "Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer" 115 : 1395-1401, 2005

21 Rossi, M., "Mechanism of induction of apoptosis by p73 and its re-levance to neuroblastoma biology" 1028 : 143-149, 2004

22 Daskalos, A., "Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer" 124 : 81-87, 2009

23 Grob, T. J., "Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53" 8 : 1213-1223, 2001

24 Daskalos, A., "Global DNA hypomethylation-induced DeltaNp73 transcriptional activation in non-small cell lung cancer" 300 : 79-86, 2011

25 Schubeler, D., "Genomic targeting of methylated DNA : influence of methylation on transcription, replication, chromatin structure, and histone acetylation" 20 : 9103-9112, 2000

26 Tosi, G. M., "Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma : implications for pathogenesis and therapeutic approach" 24 : 5827-5836, 2005

27 Griffiths, E. A., "Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia" 5 : 590-600, 2010

28 Holliday, R., "DNA modification mechanisms and gene activity during development" 187 : 226-232, 1975

29 Robertson, K. D., "DNA methylation and human disease" 6 : 597-610, 2005

30 Gore, S. D., "Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies" 2 (2): S30-S35, 2005

31 Nakagawa, T., "Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter" 22 : 2575-2585, 2002

32 Hassler, M. R., "Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine in anaplastic large cell lymphoma" 94 : 2297-2307, 2012

33 Pozniak, C. D., "An anti-apoptotic role for the p53 family member, p73, during developmental neuron death" 289 : 304-306, 2000

34 Sahu, G. R., "Alteration of p73 in pediatric de novo acute lymphoblastic leukemia" 327 : 750-755, 2005

35 Hatzimichael, E., "Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia" 33 : 1272-1275, 2009

36 Han, L. L., "Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer" 20 : 52-, 2013

37 Yu, J., "A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells" 14 : 436-446, 2007

38 Schmelz, K., "5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia" 114 : 683-695, 2005